Human FAP / Seprase Protein (ECD, His Tag) 10464-H07H from Sino Biological, Inc.

Product Specs
ItemHuman FAP / Seprase Protein (ECD, His Tag)
CompanySino Biological, Inc.
Price $398.00Supplier Page View Company Product Page
Catalog Number10464-H07H
Conjugate/TagN-His
Purity> 95 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-HPLC
TypeRecombinant protein
Molecular WeightThe recombinant human FAP consists of 751 amino acids and predicts a molecular mass of 87.2 kDa. As a result of glycosylation, rh FAP migrates as approximately 90 kDa band in SDS-PAGE under reducing conditions
SpeciesHuman
Molecule NameFAP
Source/Expression SystemHEK293 Cells
Activity1.Measured by its ability to convert the substrate benzyloxycarbonyl-Gly-Pro-7-amido-4-methylcoumarin (Z-GP-AMC) to Z-Gly-Pro and 7-amino-4-methylcoumarin (AMC). The specific activity is >1200 pmol/min/µg 2.Loaded anti-FAP antibody, human IgG1 on proA Biosensor, can bind Recombinant Human FAP Protein, His Tag (Cat. No. 10464-H07H) with an affinity constant of 0.396 nM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested). 3.Immobilized Recombinant Human FAP / Seprase Protein (ECD, His Tag) (Cat: 10464-H07H) at 1 µg/mL (100 µL/well) can bind Anti-FAP Antibody, human IgG1, the EC50 is 1.0-4.0 ng/mL (QC tested)
FormatSupplied as sterile 25mM Tris, 250mM NaCl, pH 8.2
NCBI Full Gene Namefibroblast activation protein alpha
NCBI Gene AliasesDPPIV, FAPA, FAPalpha, SIMP
Size50 µg

37 Industrial Blvd

Suite B

Paoli, PA 19301

United States

Phone: 215-583-7898
Fax: 267-657-0217

Email: marketing@sinobiological.com

(1) Chimeric antigen receptor-engineered cytolytic Tregs reverse pulmonary fibrosis and remodel the fibrotic niche without CRSJCI InsightAugust 8, 2025Yun-Han Jiang, Meng Zhou, Meng-Di Cheng, Sai Chen, Ying-Qiang Guothe Tconv numbers constant. CAR-cTregs were stimulated with 1 mg/mL FAP1 protein (Sino Biological, 10464-H07H). The proliferation of Tconv cells was quantified relative to that of unstimulated cells via cell counting.

(2) Design, Synthesis, and Biological Evaluation of a Novel [18F]AlF-H3RESCA-FAPI Radiotracer Targeting Fibroblast Activation ProteinPharmaceuticals (Basel)February 19, 2025Qingyu Zhang, Zhoumi Hu, Haitao Zhao, Fuqiang Du, Chun Lv, Tukang Peng, Yukai Zhang, Bowu Zhang, Jianjun Liu, Cheng WangAffinity Measurement In order to determine the binding kinetics between ligands and human FAP protein (10464-H07H, Sino Biological Inc., Beijing, China), the Biacore SPR interaction study was conducted. The binding

(3) Covalent targeted radioligands potentiate radionuclide therapyNatureJune 1, 2024Cui XY, Li Z, Kong Z, Liu Y, Meng H, Wen Z, Wang C, Chen J, Xu M, Li Y, et al.

(4) Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapyJournal of controlled release : official journal of the Controlled Release SocietyMay 10, 2020Yu Q, Qiu Y, Li J, Tang X, Wang X, Cun X, Xu S, Liu Y, Li M, Zhang Z, et al.

Human FAP / Seprase Protein (ECD, His Tag)